ClinicalTrials.Veeva

Menu

The Effect of Sevoflurane on Airway Hyperreactivity During the Perioperative Period.

C

China Medical University

Status

Completed

Conditions

General Anesthesia
RSV Infection in Children Less Than 5 Years of Age

Treatments

Drug: Sevoflurane (Volatile Anesthetic)
Drug: propofol

Study type

Observational

Funder types

Other

Identifiers

NCT06694675
FirstHCMU-sevoflurane

Details and patient eligibility

About

To investigate the effects of sevoflurane on respiratory parameters and respiratory inflammation in healthy and RSV-infected under general anesthesia and to propose suitable perioperative airway protection measures for children with respiratory virus infection undergoing general anesthesia.

Enrollment

97 patients

Sex

All

Ages

2 to 5 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients voluntarily joined this study and signed an informed consent form;
  2. Age: 2-5 years old;
  3. The patient should have a good general condition and no serious internal medicine comorbidities (ASA classification of the American Anesthesiology Association is Grade I); BMI ≤ 20;
  4. Plan to undergo elective adenoidectomy or adenotonsillectomy with tracheal intubation.

Exclusion criteria

  1. Children with a history of allergic asthma;
  2. Children with space-occupying lesions of the chest and lungs, or acute bronchiolitis or pneumonia;
  3. Children with cardiovascular diseases that may cause cough, wheezing, and other symptoms;
  4. Children who used leukotriene modulators, β2 receptor agonists, anticholinergics, theophyllines, or hormonal treatment drugs within two weeks;
  5. Children allergic to propofol, sevoflurane, or other anesthetic agents;
  6. Children with a family history of malignant hyperthermia;
  7. Children with liver and kidney dysfunction;
  8. The result of rapid antigen detection and nucleic acid test for RSV was inconsistent, or children combined with pathogen infections other than RSV;
  9. Children with fever.

Trial design

97 participants in 2 patient groups

Control group
Description:
The nasopharyngeal swab test for RSV antigen was negative for patients with no history of respiratory infection in the past six weeks before surgery.
Treatment:
Drug: propofol
Drug: Sevoflurane (Volatile Anesthetic)
RSV group
Description:
The nasopharyngeal swab of the RSV antigen test is positive.
Treatment:
Drug: propofol
Drug: Sevoflurane (Volatile Anesthetic)

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems